Literature DB >> 30877492

Chronic Cutaneous Lupus Erythematosus: Depression Burden and Associated Factors.

Jennifer Hong1, Laura Aspey2, Gaobin Bao3, Tamara Haynes4, S Sam Lim3, Cristina Drenkard5.   

Abstract

OBJECTIVES: Depression may occur in up to 30% of individuals with cutaneous lupus erythematosus (CLE), many of whom may also have systemic manifestations. Chronic cutaneous lupus erythematosus (CCLE) conditions are less likely to present systemic involvement than acute and subacute conditions but more often cause permanent scarring and dyspigmentation. However, little is known about depression in those who have CCLE confined to the skin (primary CCLE). As African Americans are at high risk for primary CCLE and depression, we aimed to investigate the prevalence of and explore the risk factors for depression in a population-based cohort of predominantly Black patients with primary CCLE.
METHODS: This was a cross-sectional analysis of a cohort of individuals with a documented diagnosis of primary CCLE, established in metropolitan Atlanta, GA, USA. Participants were recruited from the Centers for Disease Control and Prevention (CDC) population-based Georgia Lupus Registry, multicenter dermatology clinics, community practices, and self-referrals. The Patient-Reported Outcomes Measurement Information System (PROMIS) was used to measure the primary outcome: depressive symptoms. Stand-alone questions were used to assess sociodemographics and healthcare utilization. Emotional, informational, and instrumental support were measured with PROMIS short forms, interpersonal processes of care with the IPC-29 survey, and skin-related quality of life with the Skindex-29+ tool.
RESULTS: Of 106 patients, 92 (86.8%) were female, 91 (85.8%) were Black, 45 (42.9%) were unemployed or disabled, and 28 (26.4%) reported moderate to severe depressive symptoms. Depression severity was lower in patients who were aged ≥ 60 years, were married, or had graduated from college. Univariate analysis showed that being employed (odds ratio [OR] 0.24; 95% confidence interval [CI] 0.10-0.61), insured (OR 0.23; 95% CI 0.09-0.60), reporting higher instrumental, informational, and emotional support (OR 0.75; 95% CI 0.60-0.94; OR 0.62; 95% CI 0.49-0.78; and OR 0.48; 95% CI 0.35-0.65, respectively), visiting a primary care physician in the last year (OR 0.16; 95% CI 0.04-0.61) and reporting better physician-patient interactions (OR 0.56; 95% CI 0.37-0.87) were negatively associated with depression. Patient's perception of staff disrespect (OR 2.30; 95% CI 1.19-4.47) and worse skin-related quality of life (OR 1.04; 95% CI 1.02-1.06) rendered higher risk. In multivariate analysis, only perception of staff disrespect (OR 2.35; 95% CI 1.06-5.17) and lower emotional support (OR 0.48; 95% CI 0.35-0.66) remained associated with depression.
CONCLUSION: Over one-quarter of a predominantly Black population-based cohort of individuals with primary CCLE reported moderate to severe depression, a rate three to five times higher than described previously in the general population from the same metropolitan Atlanta area. Our findings suggest that, while patient's perception of discrimination in the healthcare setting may play a role as a determinant of depression, social support may be protective. In addition to routine mental health screening and depression treatment, interventions directed at providing emotional support and improving office staff interpersonal interactions may contribute to reduce the risk of depression in patients with CCLE.

Entities:  

Mesh:

Year:  2019        PMID: 30877492      PMCID: PMC6534449          DOI: 10.1007/s40257-019-00429-7

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  63 in total

1.  Prevalence of depression and its treatment in an elderly population: the Cache County study.

Authors:  D C Steffens; I Skoog; M C Norton; A D Hart; J T Tschanz; B L Plassman; B W Wyse; K A Welsh-Bohmer; J C Breitner
Journal:  Arch Gen Psychiatry       Date:  2000-06

2.  Socioeconomic status and mental illness: tests of the social causation and selection hypotheses.

Authors:  Christopher G Hudson
Journal:  Am J Orthopsychiatry       Date:  2005-01

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  Interpersonal processes of care in diverse populations.

Authors:  A L Stewart; A Nápoles-Springer; E J Pérez-Stable
Journal:  Milbank Q       Date:  1999       Impact factor: 4.911

5.  Psychiatric morbidity in dermatological outpatients: an issue to be recognized.

Authors:  A Picardi; D Abeni; C F Melchi; P Puddu; P Pasquini
Journal:  Br J Dermatol       Date:  2000-11       Impact factor: 9.302

6.  Postnatal depression: use of health services and satisfaction with health-care providers.

Authors:  J Webster; M A Pritchard; J W Linnane; J A Roberts; J K Hinson; S E Starrenburg
Journal:  J Qual Clin Pract       Date:  2001-12

7.  Socioeconomic status, depression disparities, and financial strain: what lies behind the income-depression relationship?

Authors:  Frederick J Zimmerman; Wayne Katon
Journal:  Health Econ       Date:  2005-12       Impact factor: 3.046

8.  Recognition of depressive and anxiety disorders in dermatological outpatients.

Authors:  Angelo Picardi; Paolo Amerio; Giannandrea Baliva; Claudio Barbieri; Patrizia Teofoli; Simone Bolli; Valentina Salvatori; Eva Mazzotti; Paolo Pasquini; Damiano Abeni
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

Review 9.  Clinical and health services relationships between major depression, depressive symptoms, and general medical illness.

Authors:  Wayne J Katon
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

Review 10.  Prevalence and incidence studies of mood disorders: a systematic review of the literature.

Authors:  Paul Waraich; Elliot M Goldner; Julian M Somers; Lorena Hsu
Journal:  Can J Psychiatry       Date:  2004-02       Impact factor: 4.356

View more
  7 in total

1.  Self-Reported Anxiety and Depression in a Monocentric Cohort of Patients With Systemic Lupus Erythematosus: Analysis of Prevalence, Main Determinants, and Impact on Quality of Life.

Authors:  Elena Elefante; Chiara Tani; Chiara Stagnaro; Viola Signorini; Beatrice Lenzi; Dina Zucchi; Francesca Trentin; Linda Carli; Francesco Ferro; Marta Mosca
Journal:  Front Med (Lausanne)       Date:  2022-03-29

Review 2.  Update on lupus epidemiology: advancing health disparities research through the study of minority populations.

Authors:  Cristina Drenkard; S Sam Lim
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

3.  Factors affecting the evolution of Chinese elderly depression: a cross-sectional study.

Authors:  Longyan Cui; Ding Ding; Junfeng Chen; Minghui Wang; Fanrong He; Shiyang Yu
Journal:  BMC Geriatr       Date:  2022-02-08       Impact factor: 3.921

4.  Using Gene Expression Analysis to Understand Complex Autoimmune Skin Disease Patients: A Series of Four Canine Cutaneous Lupus Erythematosus Cases.

Authors:  Alice A Amudzi; Cesar Piedra-Mora; Diana Junyue Ma; Neil B Wong; Clement N David; Nicholas A Robinson; Ramón M Almela; Jillian M Richmond
Journal:  Front Vet Sci       Date:  2022-02-24

Review 5.  Influence of Socio-Demographic Factors in Patients With Cutaneous Lupus Erythematosus.

Authors:  Amanda M Walker; Grace Lu; Shari C Clifton; Motolani E Ogunsanya; Benjamin F Chong
Journal:  Front Med (Lausanne)       Date:  2022-07-11

6.  Depression, stigma and social isolation: the psychosocial trifecta of primary chronic cutaneous lupus erythematosus, a cross-sectional and path analysis.

Authors:  Cristina Drenkard; Kristina A Theis; Timothy T Daugherty; Charles G Helmick; Charmayne Dunlop-Thomas; Gaobin Bao; Laura Aspey; Tené T Lewis; S Sam Lim
Journal:  Lupus Sci Med       Date:  2022-08

Review 7.  The Burden of Living With Cutaneous Lupus Erythematosus.

Authors:  Cristina Drenkard; Kamil E Barbour; Kurt J Greenlund; S Sam Lim
Journal:  Front Med (Lausanne)       Date:  2022-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.